Phase II Multicenter Study in the Preoperative Treatment of Gastric Adenocarcinoma Consisting of Chemotherapy Using Docetaxel-cisplatin-5FU + Lenograstim Followed by Chemoradiation Based 5FU and Oxaliplatin
Latest Information Update: 24 Jan 2025
Price :
$35 *
At a glance
- Drugs Docetaxel (Primary) ; Cisplatin; Fluorouracil; Oxaliplatin
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- Acronyms NESC
- 22 Jan 2025 Status changed from recruiting to completed.
- 21 Jan 2017 Results (n=33) presented at the 2017 Gastrointestinal Cancers Symposium
- 05 Apr 2012 New trial record